In situ and in silico modeling of the hematopoiesis-inducing effect of chelidonic acid
- 作者: Nasibov T.1, Gorokhova A.1, Porokhova E.1, Starosvetskaya A.1, Bariev U.1, Nosov V.1, Litvinova L.2, Avdeeva E.1, Belousov M.1, Khlusov I.1
-
隶属关系:
- Siberian State Medical University
- Immanuel Kant Baltic Federal University
- 期: 卷 27, 编号 2 (2024)
- 页面: 187-196
- 栏目: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/263674
- DOI: https://doi.org/10.46235/1028-7221-16768-ISA
- ID: 263674
如何引用文章
全文:
详细
The current trend in regenerative medicine, in the context of an aging population, is the search for new ways and means to optimize tissue bioengineering. One of the convenient models for in situ studying bone marrow regeneration is the subcutaneous ectopic osteogenesis test on scaffolds that imitate the architecture of bone tissue. Chelidonic acid (CA), a small molecule, is capable of participating in various cellular processes and metabolic pathways, and it can activate the osteogenic differentiation of mesenchymal stem cells. However, the molecular mechanisms behind the regulatory effects of CA remain unknown. The aim of this study was to investigate the modulatory effect of CA on the in situ formation of hematopoietic foci, as well as to predict target genes and intracellular signalling pathways involved in the hematopoietic activity of CA. An aqueous solution of CA, isolated from an extract of the Saussurea controversa plant. Course (daily for 35 days) oral administration of CA. Ectopic osteogenesis testing in Balb/c mice. Morphometric analysis of histological sections after 45 days and in silico modelling of gene expression with statistical analysis. CA, when administered orally in a low dose (10 mg/kg), threefold increases the normalized area of bone marrow in the composition of bone tissue plates grown in situ in a test of ectopic subcutaneous osteogenesis in mice. This effect is associated essentially (a probability of CA activity Pa > 0.5 and a probability of inactivity Pi < 0.5) with enhanced expression of 358 hematopoiesis-related genes, as predicted by in silico analysis. The top list with the highest Pa value included 10 target genes, such as GATA1, CITED2, SFRP1, EP300, LGALS9, VNN1, IL10RB, RARA, CD83, and HMOX1. CA has a significant ability to enhance the reparative remodelling of hematopoietic tissue in situ. The next phase of research will be to test actual target genes and signalling pathways that mediate the regulatory effect of HC on hematopoiesis both in vitro and in vivo, as well as in clinical settings.
作者简介
T. Nasibov
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Laboratory Assistant, Laboratory of Cellular and Microfluidic Technologies
俄罗斯联邦, TomskA. Gorokhova
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Laboratory Assistant, Laboratory of Cellular and Microfluidic Technologies
俄罗斯联邦, TomskE. Porokhova
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Assistant Professor, Department of Morphology and General Pathology
俄罗斯联邦, TomskA. Starosvetskaya
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Student of the Faculty of Medicine and Biology
俄罗斯联邦, TomskU. Bariev
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Student of the Faculty of Medicine
俄罗斯联邦, TomskV. Nosov
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
Laboratory Assistant, Department of Normal Physiology
俄罗斯联邦, TomskL. Litvinova
Immanuel Kant Baltic Federal University
Email: khlusov.ia@ssmu.ru
PhD, MD (Medicine), Director, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradE. Avdeeva
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
PhD, MD (Pharmaceutical), Research Associate, Laboratory of Cellular and Microfluidic Technologies
俄罗斯联邦, TomskMikhail Belousov
Siberian State Medical University
Email: khlusov.ia@ssmu.ru
PhD, MD (Pharmaceutical), Leading Research Associate, Laboratory of Cellular and Microfluidic Technologies
俄罗斯联邦, TomskI. Khlusov
Siberian State Medical University
编辑信件的主要联系方式.
Email: khlusov.ia@ssmu.ru
PhD, MD (Medicine), Professor, Chief, Laboratory of Cellular and Microfluidic Technologies
俄罗斯联邦, Tomsk参考
- Мирошниченко Л.А., Полякова Т.Ю., Авдеева Е.Ю., Кривощеков С.В., Хлусов И.А., Белоусов М.В. Хелидоновая кислота и ее дериваты: общий спектр биологической активности и остеогенные свойства // Разработка и регистрация лекарственных средств, 2022, Т. 11, № 4, С. 60-71. [Miroshnichenko L.A., Polyakova T.U., Avdeeva E.Yu., Krivoshchekov S.V., Khlusov I.A., Belousov M.V. Chelidonic acid and its derivatives: general spectrum of biological activity and osteogenic properties. Razrabotka i registraciya lekarstvennyh sredstv = Development and Registration of Medicines, 2022, Vol. 11, no. 4, pp. 60-71. (In Russ.)]
- Avdeeva E., Porokhova E., Khlusov I., Rybalova T., Shults E., Litvinova L., Shupletsova V., Khaziakhmatova O., Sukhodolo I., Belousov M. Calcium chelidonate: semi-synthesis, crystallography, and osteoinductive activity in vitro and in vivo. Pharmaceuticals (Basel), 2021, Vol. 14, no. 6, 579. doi: 10.3390/ph14060579.
- Avdeeva E., Shults E., Rybalova T., Reshetov Y., Porokhova E., Sukhodolo I., Litvinova L., Shupletsova V., Khaziakhmatova O., Khlusov I., Guryev A., Belousov M. Chelidonic acid and its derivatives from saussurea controversa: isolation, structural elucidation and influence on the osteogenic differentiation of multipotent mesenchymal stromal cells in vitro. Biomolecules, 2019, Vol. 9, no. 5, 189. doi: 10.3390/biom9050189.
- Brunner-Munzel Test // CRAN. Access mode: https://search.rproject.org/CRAN/refmans/brunnermunzel/html/00Index.html (Accessed 22 February 2024).
- Chan C.K., Chen C.C., Luppen C.A., Kim J.B., DeBoer A.T., Wei K., Helms J.A., Kuo C.J., Kraft D.L., Weissman I.L. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature, 2009, Vol. 457, no. 7228, pp. 490-494.
- Filimonov D.A., Lagunin A.A., Gloriozova T.A., Rudik A.V., Druzhilovskii D.S., Pogodin P.V., Poroikov V.V. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem. Heterocycl. Compd., 2014, Vol. 50, no. 3, pp. 444-457.
- Korkmaz S., Göksülük D., Zararsiz G. MVN: An R package for assessing multivariate normality. R Journal, 2014, Vol. 6, no. 2, pp. 151-162.
- Lagunin A., Ivanov S., Rudik A., Filimonov D., Poroikov V. DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula. Bioinformatics, 2013, Vol. 29, no. 16, pp. 2062-2063.
- Scott M.A., Levi B., Askarinam A., Nguyen A., Rackohn T., Ting K., Soo C. James A.W. Brief review of models of ectopic bone formation. Stem Cells Dev., 2012, Vol. 21, no. 5, pp. 655-667.
- Slenter D.N., Kutmon M., Hanspers K., Riutta A., Windsor J., Nunes N., Mélius J., Cirillo E., Coort S.L., Digles D., Ehrhart F., Giesbertz P., Kalafati M., Martens M., Miller R., Nishida K., Rieswijk L., Waagmeester A., Eijssen L.M.T., Evelo C.T., Willighagen E.L. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res., 2018, Vol. 46, no. D1, pp. D661-D667.
- Wu T., Hu E., Xu S., Chen M., Guo P., Dai Z., Feng T., Zhou L., Tang W., Zhan L., Fu X., Liu S., Bo X., Yu G. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb), 2021, Vol. 2, no. 3, 100141. doi: 10.1016/j.xinn.2021.100141.
- Yu G., Wang L.G., Yan G.R., He Q.Y. DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics, 2015, Vol. 31, no. 4, pp. 608-609.
- Yurova K.A., Khaziakhmatova O.G., Melashchenko E.S., Malashchenko V.V., Shunkin E.O., Shupletsova V.V., Ivanov P.A., Khlusov I.A., Litvinova L.S. Cellular and molecular basis of osteoblastic and vascular niches in the processes of hematopoiesis and bone remodeling (a short review of modern views). Curr. Pharm. Des., 2019, Vol. 25, no. 6, pp. 663-669.